文献速递免疫规划传染病防控与疫情报告

重组马疱疹病毒1型与改良安卡拉痘苗病毒载体递送的施马伦贝格病毒包膜蛋白Gc N端结构域:牛的免疫原性与保护效力

N-terminal domain of Schmallenberg virus envelope protein Gc delivered by recombinant equine herpesvirus type 1 and modified vaccinia virus Ankara: Immunogenicity and protective efficacy in cattle.
PubMed 文献 · Vaccine · 2018-07-23

本研究在牛中测试了以重组马疱疹病毒1型(EHV-1)或改良安卡拉痘苗病毒(MVA)载体递送施马伦贝格病毒(SBV)包膜蛋白Gc N端结构域的疫苗。EHV-1载体疫苗使4头牛中2头获得保护,而MVA载体疫苗诱导SBV特异性抗体应答并使所有接种牛获得完全保护。两种载体疫苗均不诱导针对SBV N蛋白的抗体,可区分疫苗接种与野毒感染动物。

要点

  • MVA载体递送Gc N端结构域疫苗诱导SBV特异性抗体应答,使所有接种牛获得完全保护。
  • EHV-1载体疫苗使4头牛中2头获得保护。
  • 两种载体疫苗均不诱导抗SBV N蛋白抗体,可区分接种与野毒感染动物。

核心结论

  • MVA载体疫苗高效诱导SBV特异性抗体应答并使所有接种牛获得完全保护,EHV-1载体疫苗使4头牛中2头获得保护。
  • 两种载体疫苗因不诱导抗SBV N蛋白抗体,可区分疫苗接种与野毒感染动物,有望成为控制SBV传播及预防家养反刍动物疾病的工具。

研究设计与样本

  • 在牛中开展疫苗接种-攻毒试验,测试重组EHV-1或MVA载体递送的SBV包膜蛋白Gc N端结构域。

主要发现

  • EHV-1载体疫苗使4头牛中2头获得保护。
  • MVA载体疫苗诱导SBV特异性抗体应答,并使所有接种牛获得完全保护。
  • 两种载体疫苗均不诱导针对SBV N蛋白的抗体。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Schmallenberg virus (SBV), which emerged in 2011 in Central Europe and subsequently spread very rapidly throughout the continent, affects predominantly ruminants. SBV is transmitted by insect vectors, and therefore vaccination is one of the major tools of disease control. Only recently, a domain connected to virus neutralization has been identified at the amino-terminal part of the viral envelope protein Gc. Here, this Gc domain delivered by recombinant EHV-1 or MVA vector viruses was tested in a vaccination-challenge trial in cattle, one of the major target species of SBV. The EHV-1-based vaccine conferred protection in two of four animals, whereas immunization using the MVA vector vaccine efficiently induced an SBV-specific antibody response and full protection against SBV challenge infection in all the vaccinated animals. Moreover, due to the absence of antibodies against SBVs N-protein, both vector vaccines enable the differentiation between vaccinated and field-infected animals making them to a promising tool to control SBV spread as well as to prevent disease in domestic ruminants.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wernike K, Mundt A, Link EK, et al. N-terminal domain of Schmallenberg virus envelope protein Gc delivered by recombinant equine herpesvirus type 1 and modified vaccinia virus Ankara: Immunogenicity and protective efficacy in cattle. Vaccine. 2018. PMID: 30049630. doi:10.1016/j.vaccine.2018.07.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。